500,000
Participants
Start Date
February 19, 2024
Primary Completion Date
December 31, 2037
Study Completion Date
December 31, 2037
Observational
Observational
Columbia University Irving Medical Center/ New York Presbyterian Hospital, New York
University of Pennsylvania, Philadelphia
Georgetown Medstar Transplant Institute, Washington D.C.
Atrium Health Center for Liver Disease and Transplant, Charlotte
Rush University Medical Center, Chicago
Baylor Scott & White Research Institute, Dallas
Baylor College of Medicine, Houston
Stanford Medicine, Redwood City
Target PharmaSolutions, Inc.
INDUSTRY